222 related articles for article (PubMed ID: 12909738)
21. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.
Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB
Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848
[TBL] [Abstract][Full Text] [Related]
22. High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.
Sohn TA; Su GH; Ryu B; Yeo CJ; Kern SE
Ann Surg; 2001 May; 233(5):696-703. PubMed ID: 11323508
[TBL] [Abstract][Full Text] [Related]
23. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
24. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
Walters DM; Stokes JB; Adair SJ; Stelow EB; Borgman CA; Lowrey BT; Xin W; Blais EM; Lee JK; Papin JA; Parsons JT; Bauer TW
PLoS One; 2013; 8(10):e77065. PubMed ID: 24204737
[TBL] [Abstract][Full Text] [Related]
25. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
[TBL] [Abstract][Full Text] [Related]
26. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
27. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
28. [Detection of the expression of Smad4, transforming growth factor beta(1) and beta receptor II proteins in paraffin-embedded human pancreatic cancer tissues].
Gu L; Chen J; Liu T; Li L; Lu Z; Luo Y
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):439-42. PubMed ID: 11866987
[TBL] [Abstract][Full Text] [Related]
29. SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivo.
Cattaneo M; Orlandini S; Beghelli S; Moore PS; Sorio C; Bonora A; Bassi C; Talamini G; Zamboni G; Orlandi R; Ménard S; Bernardi LR; Biunno I; Scarpa A
Oncogene; 2003 Sep; 22(41):6359-68. PubMed ID: 14508516
[TBL] [Abstract][Full Text] [Related]
30. Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.
Fullerton PT; Creighton CJ; Matzuk MM
Mol Endocrinol; 2015 Oct; 29(10):1440-53. PubMed ID: 26284758
[TBL] [Abstract][Full Text] [Related]
31. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
33. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
[TBL] [Abstract][Full Text] [Related]
34. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
Tascilar M; Skinner HG; Rosty C; Sohn T; Wilentz RE; Offerhaus GJ; Adsay V; Abrams RA; Cameron JL; Kern SE; Yeo CJ; Hruban RH; Goggins M
Clin Cancer Res; 2001 Dec; 7(12):4115-21. PubMed ID: 11751510
[TBL] [Abstract][Full Text] [Related]
35. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs.
Lin SZ; Xu JB; Ji X; Chen H; Xu HT; Hu P; Chen L; Guo JQ; Chen MY; Lu D; Wang ZH; Tong HF
Mol Med Rep; 2015 Oct; 12(4):5865-71. PubMed ID: 26238071
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of the TGF-beta postreceptor signaling pathway in cell lines derived from primary or metastatic ovarian cancer.
Xi L; Hu W; Meng L; Zhou J; Lu Y; Wang C; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):62-5. PubMed ID: 15165118
[TBL] [Abstract][Full Text] [Related]
37. Induction and expression of betaig-h3 in pancreatic cancer cells.
Schneider D; Kleeff J; Berberat PO; Zhu Z; Korc M; Friess H; Büchler MW
Biochim Biophys Acta; 2002 Oct; 1588(1):1-6. PubMed ID: 12379307
[TBL] [Abstract][Full Text] [Related]
38. DPC4/SMAD4 gene alterations in human cancer, and their functional implications.
Schutte M
Ann Oncol; 1999; 10 Suppl 4():56-9. PubMed ID: 10436786
[TBL] [Abstract][Full Text] [Related]
39. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
40. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]